BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 34258920)

  • 1. The pathomechanism of human myxomatous valvular degeneration at the mechanical and cellular level.
    Hu C; Wang Q; Xue H; Hong H; Shi J; Dong N; Zhang M
    Rev Cardiovasc Med; 2021 Jun; 22(2):513-519. PubMed ID: 34258920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activated interstitial myofibroblasts express catabolic enzymes and mediate matrix remodeling in myxomatous heart valves.
    Rabkin E; Aikawa M; Stone JR; Fukumoto Y; Libby P; Schoen FJ
    Circulation; 2001 Nov; 104(21):2525-32. PubMed ID: 11714645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smooth Muscle α-Actin Expression in Mitral Valve Interstitial Cells is Important for Mediating Extracellular Matrix Remodeling.
    Dye BK; Butler C; Lincoln J
    J Cardiovasc Dev Dis; 2020 Aug; 7(3):. PubMed ID: 32824919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interstitial cells from dogs with naturally occurring myxomatous mitral valve disease undergo phenotype transformation.
    Disatian S; Ehrhart EJ; Zimmerman S; Orton EC
    J Heart Valve Dis; 2008 Jul; 17(4):402-11; discussion 412. PubMed ID: 18751470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Could activated tissue remodeling be considered as early marker for progressive valve degeneration? Comparative analysis of checkpoint and ECM remodeling gene expression in native degenerating aortic valves and after bioprosthetic replacement.
    Yeghiazaryan K; Skowasch D; Bauriedel G; Schild H; Golubnitschaja O
    Amino Acids; 2007 Jan; 32(1):109-14. PubMed ID: 16874466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic and reversible changes of interstitial cell phenotype during remodeling of cardiac valves.
    Rabkin-Aikawa E; Farber M; Aikawa M; Schoen FJ
    J Heart Valve Dis; 2004 Sep; 13(5):841-7. PubMed ID: 15473488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac transgenic matrix metalloproteinase-2 expression induces myxomatous valve degeneration: a potential model of mitral valve prolapse disease.
    Mahimkar R; Nguyen A; Mann M; Yeh CC; Zhu BQ; Karliner JS; Lovett DH
    Cardiovasc Pathol; 2009; 18(5):253-61. PubMed ID: 18835790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and Evaluation of a Tissue-Engineered Fibrin-based Canine Mitral Valve Three-dimensional Cell Culture System.
    Liu MM; Flanagan TC; Jockenhovel S; Black A; Lu CC; French AT; Argyle DJ; Corcoran BM
    J Comp Pathol; 2018 Apr; 160():23-33. PubMed ID: 29729718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the Interleukin-33/ST2 Pathway Exerts Deleterious Effects in Myxomatous Mitral Valve Disease.
    Garcia-Pena A; Ibarrola J; Navarro A; Sadaba A; Tiraplegui C; Garaikoetxea M; Arrieta V; Matilla L; Fernández-Celis A; Sadaba R; Alvarez V; Gainza A; Jover E; López-Andrés N
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33669101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteopontin alters endothelial and valvular interstitial cell behaviour in calcific aortic valve stenosis through HMGB1 regulation.
    Passmore M; Nataatmadja M; Fung YL; Pearse B; Gabriel S; Tesar P; Fraser JF
    Eur J Cardiothorac Surg; 2015 Sep; 48(3):e20-9. PubMed ID: 26273067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local serotonin mediates cyclic strain-induced phenotype transformation, matrix degradation, and glycosaminoglycan synthesis in cultured sheep mitral valves.
    Lacerda CM; Kisiday J; Johnson B; Orton EC
    Am J Physiol Heart Circ Physiol; 2012 May; 302(10):H1983-90. PubMed ID: 22345569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ADAMTS5 Deficiency in Calcified Aortic Valves Is Associated With Elevated Pro-Osteogenic Activity in Valvular Interstitial Cells.
    Li F; Song R; Ao L; Reece TB; Cleveland JC; Dong N; Fullerton DA; Meng X
    Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1339-1351. PubMed ID: 28546218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defining the Role of the miR-145-KLF4-αSMA Axis in Mitral Valvular Interstitial Cell Activation in Myxomatous Mitral Valve Prolapse Using the Canine Model.
    Yang VK; Moyer N; Zhou R; Carnevale SZ; Meola DM; Robinson SR; Li G; Das S
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory regulation of extracellular matrix remodeling in calcific aortic valve stenosis.
    Kaden JJ; Dempfle CE; Grobholz R; Fischer CS; Vocke DC; Kiliç R; Sarikoç A; Piñol R; Hagl S; Lang S; Brueckmann M; Borggrefe M
    Cardiovasc Pathol; 2005; 14(2):80-7. PubMed ID: 15780799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human myxomatous mitral valve prolapse: role of bone morphogenetic protein 4 in valvular interstitial cell activation.
    Sainger R; Grau JB; Branchetti E; Poggio P; Seefried WF; Field BC; Acker MA; Gorman RC; Gorman JH; Hargrove CW; Bavaria JE; Ferrari G
    J Cell Physiol; 2012 Jun; 227(6):2595-604. PubMed ID: 22105615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tryptophan hydroxylase 1 expression is increased in phenotype-altered canine and human degenerative myxomatous mitral valves.
    Disatian S; Lacerda C; Orton EC
    J Heart Valve Dis; 2010 Jan; 19(1):71-8. PubMed ID: 20329492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrastructural morphologic evaluation of the phenotype of valvular interstitial cells in dogs with myxomatous degeneration of the mitral valve.
    Black A; French AT; Dukes-McEwan J; Corcoran BM
    Am J Vet Res; 2005 Aug; 66(8):1408-14. PubMed ID: 16173485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of cellular changes in Cavalier King Charles spaniel and mixed breed dogs with myxomatous mitral valve disease.
    Lu CC; Liu MM; Culshaw G; French A; Corcoran B
    J Vet Cardiol; 2016 Jun; 18(2):100-9. PubMed ID: 26860643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative pathology of human and canine myxomatous mitral valve degeneration: 5HT and TGF-β mechanisms.
    Oyama MA; Elliott C; Loughran KA; Kossar AP; Castillero E; Levy RJ; Ferrari G
    Cardiovasc Pathol; 2020; 46():107196. PubMed ID: 32006823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for an altered balance between matrix metalloproteinase-9 and its inhibitors in calcific aortic stenosis.
    Satta J; Oiva J; Salo T; Eriksen H; Ohtonen P; Biancari F; Juvonen TS; Soini Y
    Ann Thorac Surg; 2003 Sep; 76(3):681-8; discussion 688. PubMed ID: 12963177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.